Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Leukemia, Published online: 25 October 2023; doi:10.1038/s41375-023-02042-4Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (Source: Leukemia)
Source: Leukemia - October 25, 2023 Category: Hematology Authors: Arend v. Stackelberg Katja J äschke Etienne Jousseaume Corinna Templin Ulli Jeratsch Daniela Kosmides Ingo Steffen Nicola G ökbuget Christina Peters Source Type: research
Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation
Leukemia, Published online: 25 October 2023; doi:10.1038/s41375-023-02072-yPrognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation (Source: Leukemia)
Source: Leukemia - October 25, 2023 Category: Hematology Authors: Lara Bischof Jule Ussmann Juliane Grimm Marius Bill Dominic Brauer Donata Backhaus Lisa Herrmann Maximilian Merz Marco Herling Klaus H. Metzeler Georg-Nikolaus Franke Vladan Vucinic Uwe Platzbecker Sebastian Schwind Madlen Jentzsch Source Type: research
Clinical landscape of TP73 structural variants in ATL patients
Leukemia, Published online: 20 October 2023; doi:10.1038/s41375-023-02059-9Clinical landscape of TP73 structural variants in ATL patients (Source: Leukemia)
Source: Leukemia - October 20, 2023 Category: Hematology Authors: Hiroaki Hiramatsu Rui Yokomori Liu Shengyi Norio Tanaka Seiichi Mori Kazuma Kiyotani Osamu Gotoh Shigeru Kusumoto Nobuaki Nakano Youko Suehiro Asahi Ito Ilseung Choi Eiichi Ohtsuka Michihiro Hidaka Kisato Nosaka Makoto Yoshimitsu Yoshitaka Imaizumi Shinsu Source Type: research
RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort
Leukemia, Published online: 20 October 2023; doi:10.1038/s41375-023-02027-3RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort (Source: Leukemia)
Source: Leukemia - October 20, 2023 Category: Hematology Authors: J. M. O ’Sullivan J. Taylor A. Gerds S. Buckley C. N. Harrison S. Oh A. F. List K. Howard H. Dreau A. Hamblin A. J. Mead Source Type: research
Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice
Leukemia, Published online: 19 October 2023; doi:10.1038/s41375-023-02067-9Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice (Source: Leukemia)
Source: Leukemia - October 19, 2023 Category: Hematology Authors: Tiago L. Duarte Marta Lopes M ónica Oliveira Ana G. Santos Catarina Vasco Joana P. Reis Ana Rita Antunes Andreia Gon çalves S érgio Chacim Cl áudia Oliveira Beatriz Porto Maria Jos é Teles Ana C. Moreira Andr é M. N. Silva Ron Schwessinger Hal Drake Source Type: research
Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma
Leukemia, Published online: 17 October 2023; doi:10.1038/s41375-023-02065-xBispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma (Source: Leukemia)
Source: Leukemia - October 17, 2023 Category: Hematology Authors: Chenggong Li Jia Xu Wenjing Luo Danying Liao Wei Xie Qiuzhe Wei Yinqiang Zhang Xindi Wang Zhuolin Wu Yun Kang Jin ’e Zheng Wei Xiong Jun Deng Yu Hu Heng Mei Source Type: research
Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis
Leukemia, Published online: 17 October 2023; doi:10.1038/s41375-023-02062-0Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis (Source: Leukemia)
Source: Leukemia - October 17, 2023 Category: Hematology Authors: Andrew Wu Ryan Yen Sarah Grasedieck Hanyang Lin Helen Nakamoto Donna L. Forrest Connie J. Eaves Xiaoyan Jiang Source Type: research
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma
Leukemia, Published online: 16 October 2023; doi:10.1038/s41375-023-02064-yFollow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma (Source: Leukemia)
Source: Leukemia - October 16, 2023 Category: Hematology Authors: Michael Fuchs Anne Sophie Jacob Helen Kaul Carsten Kobe Georg Kuhnert Thomas Pabst Richard Greil Paul J. Br öckelmann Max S. Topp Marianne Just Bernd Hertenstein Martin Soekler Martin Vogelhuber Jos ée M. Zijlstra Ulrich Bernd Keller Stefan W. Krause Ul Source Type: research
The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations
Leukemia, Published online: 16 October 2023; doi:10.1038/s41375-023-02060-2The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations (Source: Leukemia)
Source: Leukemia - October 16, 2023 Category: Hematology Authors: Duoduo Zhao Christian Rohde Stefanie G öllner Fengbiao Zhou Cornelius Pauli Maximilian Felix Blank Rafael Zinz Anna Luise Grab Alexandra M. Poos Lukas John Stefanie Huhn Marc-Steffen Raab Carsten M üller-Tidow Niels Weinhold Source Type: research
Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL
Leukemia, Published online: 16 October 2023; doi:10.1038/s41375-023-02058-wRecurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL (Source: Leukemia)
Source: Leukemia - October 16, 2023 Category: Hematology Authors: Željko Antić Alena van B ömmel Konstantin Riege Jana Lentes Charlotte Schr öder Julia Alten Cornelia Eckert Lara Fuhrmann Doris Steinemann Lennart Lenk Denis M. Schewe Martin Zimmermann Martin Schrappe Brigitte Schlegelberger Gunnar Cario Steve Hoffma Source Type: research
Idasanutlin and navitoclax induce synergistic apoptotic cell death in T-cell acute lymphoblastic leukemia
Leukemia, Published online: 14 October 2023; doi:10.1038/s41375-023-02057-xIdasanutlin and navitoclax induce synergistic apoptotic cell death in T-cell acute lymphoblastic leukemia (Source: Leukemia)
Source: Leukemia - October 14, 2023 Category: Hematology Authors: Kimberly B. Johansson Megan S. Zimmerman Iryna V. Dmytrenko Feng Gao Daniel C. Link Source Type: research
Single-cell RNA sequencing of a new transgenic t(8;21) preleukemia mouse model reveals regulatory networks promoting leukemic transformation
Leukemia, Published online: 14 October 2023; doi:10.1038/s41375-023-02063-zSingle-cell RNA sequencing of a new transgenic t(8;21) preleukemia mouse model reveals regulatory networks promoting leukemic transformation (Source: Leukemia)
Source: Leukemia - October 14, 2023 Category: Hematology Authors: Ming Yan Mengdan Liu Amanda G. Davis Samuel A. Stoner Dong-Er Zhang Source Type: research
Measurable residual disease in chronic lymphocytic leukemia. Where do we stand?
Leukemia, Published online: 14 October 2023; doi:10.1038/s41375-023-02066-wMeasurable residual disease in chronic lymphocytic leukemia. Where do we stand? (Source: Leukemia)
Source: Leukemia - October 14, 2023 Category: Hematology Authors: Ilaria Del Giudice Robin Fo à Source Type: research
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
Leukemia, Published online: 13 October 2023; doi:10.1038/s41375-023-02061-1Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia (Source: Leukemia)
Source: Leukemia - October 13, 2023 Category: Hematology Authors: Jan-Niklas Eckardt Sebastian Stasik Christoph R öllig Andreas Petzold Tim Sauer Sebastian Scholl Andreas Hochhaus Martina Crysandt Tim H. Br ümmendorf Ralph Naumann Bj örn Steffen Volker Kunzmann Hermann Einsele Markus Schaich Andreas Burchert Andreas Source Type: research
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders
Leukemia, Published online: 11 October 2023; doi:10.1038/s41375-023-02056-yHigh-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders (Source: Leukemia)
Source: Leukemia - October 11, 2023 Category: Hematology Authors: Sebastian K öhrer Tobias Dittrich Martin Schorb Niels Weinhold Isabella Haberbosch Mandy B örmel Gabor Pajor Hartmut Goldschmidt Carsten M üller-Tidow Marc S. Raab Lukas John Anja Seckinger Alexander Brobeil Peter Dreger Tam ás Tornóczky L ászló Pa Source Type: research
